Optimizing the Clinical Fit of Auditory Brain Stem
Implants
Christopher J. Long, Ian Nimmo-Smith, David M. Baguley, Martin O’Driscoll,
Richard Ramsden, Steven R. Otto, Patrick R. Axon, and Robert P. Carlyon
Objective: To develop and implement a new audio-
logical fitting procedure for auditory brain stem
implants (ABIs), based on an efficient algorithm,
and to compare it with two procedures presently
used in clinical practice.
Design: First, the different procedures were com-
pared by using computer models and simulations
with normal-hearing subjects (N 4). This allows
for an analysis of the accuracy of the procedures in
a way that is not possible when testing ABI users.
The root-mean-square error between the order es-
timated by the procedure and the true order was
calculated. In addition, ABI users (N 2) were
tested with the new procedure to see if it could be
successfully applied in clinic. The degree of vari-
ability of their results across runs and sessions was
analyzed.
Results: The tests of the normal-hearing subjects
showed that our proposed procedure required sig-
nificantly fewer trials (22 on average) than proce-
dures presently used in clinic (with 76 and 234 trials
on average for the two other procedures tested) to
produce the same degree of accuracy. Computer
modeling also demonstrated this advantage. Addi-
tional testing showed this advantage was main-
tained under a variety of conditions relevant to the
clinic. The two patients tested were able to use this
procedure with success, even though they were
poor at discriminating the pitch of electrodes. The
patients showed results consistent with having
about 4 to 5 discriminable groups of electrodes with
the 12 to 14 electrodes tested.
Conclusions: The proposed procedure requires
fewer trials to produce a clinically useful result and
is well tolerated in the clinic. An additional advan-
tage is that it allows testing to be broken down into
several “blocks,” each containing a small number of
trials. If the variability between blocks is small,
information can be combined across blocks to in-
crease the accuracy of the result. If the variability is
large, perhaps between blocks on different days,
this may reflect a significant change in the percepts
generated by the implant, and signal to the clinician
that a significant alteration in the fitting is re-
quired. We recommend its use in ABI user fitting
and in cochlear implant fitting when pitch ranking
is problematic.
(Ear & Hearing 2005;26;251–262)
For many patients with profound sensory hearing
loss of cochlear origin, cochlear implants can restore
useful hearing by electrically stimulating the resid-
ual neural structures, probably the spiral ganglion
cells. For a cochlear implant to function, it requires
the presence of the auditory nerve to connect the
cochlea to the brainstem. Neurofibromatosis type II
(NFII) is a condition characterized by bilateral tu-
mors of the auditory-vestibular nerves (vestibular
schwannomas). Patients with NFII nearly always
have a severe-to-profound hearing loss due either to
the destruction of the auditory nerves by the tumors
themselves or by the surgery to remove the tumors.
For such people, some hearing ability may be re-
stored by an auditory brain stem implant (ABI).
ABIs do not provide the same level of benefit as
multi-channel cochlear implants. One reason for
this may be that the ABI, which is typically placed
over the surface of the dorsal cochlear nucleus, does
not usually excite neural elements in a tonotopically
ordered way, perhaps because many of the cells and
their dendrites run parallel to the surface (Moore,
1987). This contrasts with the situation for cochlear
implants, in which it is known a priori that elec-
trodes positioned in the basal end of the cochlea will
produce higher pitches than those located in the
apical end. Accordingly, clinicians have to rely on
ABI patients’ reports of the relative pitches pro-
duced by each electrode to map higher-frequency
bands of sound onto electrodes that evoke progres-
sively higher pitches. This approach has been shown
to provide significant benefits to speech perception:
For example, Otto (Reference note 1) compared
speech perception in users of the Nucleus ABI (Co-
chlear Limited) with the electrodes assigned to fre-
quency channels in a pitch-ranked order with that
when the assignment was random. The pitch rank-
ing produced substantial improvements in tests of
speech perception; from 20 to 55% correct for vowel
MRC Cognition and Brain Sciences Unit (C.J.L., I.N.-S., R.P.C.),
Cambridge, United Kingdom; Department of Oto-Neurological
Surgery (D.M.B., P.R.A.), Addenbrooke’s Hospital, Cambridge,
United Kingdom; Manchester Royal Infirmary (M.O., R.R.),
Manchester, United Kingdom; and Auditory Implants and Per-
ception (S.R.O.), House Ear Institute, Los Angeles, California,
0196/0202/05/2603-0251/0 • Ear & Hearing • Copyright © 2005 by Lippincott Williams & Wilkins • Printed in the U.S.A.
251